within Pharmacolibrary.Drugs.ATC.J;

model J01DE01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.08,
    adminDuration  = 600,
    adminMass      = 2.0,
    adminCount     = 1,
    Vd             = 0.018,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Cefepime is a fourth-generation cephalosporin antibiotic with broad-spectrum activity against Gram-positive and Gram-negative bacteria. It is commonly used for serious bacterial infections, including pneumonia, urinary tract infections, skin infections, and febrile neutropenia. Cefepime is administered parenterally and is approved for clinical use worldwide.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adults after a single 2 g intravenous dose infused over 30 minutes.</p><h4>References</h4><ol><li><p>Jumpertz, M, et al., &amp; Cassir, N (2022). Subcutaneously administered antibiotics: a review. <i>The Journal of antimicrobial chemotherapy</i> 78(1) 1–7. DOI:<a href=&quot;https://doi.org/10.1093/jac/dkac383&quot;>10.1093/jac/dkac383</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36374566/&quot;>https://pubmed.ncbi.nlm.nih.gov/36374566</a></p></li><li><p>Zhanel, GG, et al., &amp; Karlowsky, JA (2019). Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli. <i>Drugs</i> 79(3) 271–289. DOI:<a href=&quot;https://doi.org/10.1007/s40265-019-1055-2&quot;>10.1007/s40265-019-1055-2</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/30712199/&quot;>https://pubmed.ncbi.nlm.nih.gov/30712199</a></p></li><li><p>Barbhaiya, RH, et al., &amp; Martin, RR (1992). Pharmacokinetics of cefepime after single and multiple intravenous administrations in healthy subjects. <i>Antimicrobial agents and chemotherapy</i> 36(3) 552–557. DOI:<a href=&quot;https://doi.org/10.1128/AAC.36.3.552&quot;>10.1128/AAC.36.3.552</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1622165/&quot;>https://pubmed.ncbi.nlm.nih.gov/1622165</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end J01DE01;
